Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon Brown

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Molecular Cancer Therapeutics|January 24, 2007
Molecular correlates of gefitinib responsiveness in human bladder cancer cellsMarissa Shrader, Maria Simona Pino, Gordon Brown, et al.
BJU International|May 3, 2014
Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgeryKetan K Badani, Darby J Thompson, Gordon Brown, et al.
Journal of Public Health (Oxford, England)|May 25, 2019
Case epidemiology from the first three years of a pilot laboratory-based surveillance system for elevated blood-lead concentrations among children in England, 2014-17: implications for public health actionD J Roberts, Helen Crabbe, Tayo Owodunni, et al.
Urologic Oncology|April 20, 2023
Comparison of prostate-specific antigen response in patients with metastatic castration-sensitive prostate cancer initiated on apalutamide or abiraterone acetate: A retrospective cohort studyBenjamin Lowentritt, Dominic Pilon, Dexter Waters, et al.
Advances in Therapy|June 17, 2025
Comparison of Real-World Outcomes between Patients with BRCA1/2-Positive and Homologous Recombination Repair-Negative Metastatic Castration-Sensitive Prostate CancerMehmet A Bilen, Sabree Burbage, Carmine Rossi, et al.
Journal of Intellectual Disability Research : JIDR|October 20, 2025
Implementation of Online Mindfulness With Peer Mentoring for Parent and Sibling Carers of People With Intellectual and Developmental DisabilitiesCaitlin A Murray, Nikita K Hayden, Alex Gordon-Brown, et al.
Chemical Communications (Cambridge, England)|September 25, 2014
Dual doping effects (site blockage and electronic promotion) imposed by adatoms on Pd nanocrystals for catalytic hydrogen productionS Jones, S M Fairclough, M Gordon-Brown, et al.
Prostate Cancer and Prostatic Diseases|October 1, 2021
Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studiesErik Margolis, Gordon Brown, Alan Partin, et al.
International Urology and Nephrology|March 19, 2024
Renal mass imaging modalities: does body mass index (BMI) matter?Young Son, Mark E Quiring, Raeann M Dalton, et al.
Urology|January 31, 2026
Homologous recombination repair mutations, next-generation sequencing testing, and treatment progression by race among patients with metastatic castration-sensitive prostate cancerMehmet A Bilen, Neal Shore, Sabree Burbage, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Molecular Cancer Therapeutics|January 24, 2007
Molecular correlates of gefitinib responsiveness in human bladder cancer cellsMarissa Shrader, Maria Simona Pino, Gordon Brown, et al.
BJU International|May 3, 2014
Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgeryKetan K Badani, Darby J Thompson, Gordon Brown, et al.
Journal of Public Health (Oxford, England)|May 25, 2019
Case epidemiology from the first three years of a pilot laboratory-based surveillance system for elevated blood-lead concentrations among children in England, 2014-17: implications for public health actionD J Roberts, Helen Crabbe, Tayo Owodunni, et al.
Urologic Oncology|April 20, 2023
Comparison of prostate-specific antigen response in patients with metastatic castration-sensitive prostate cancer initiated on apalutamide or abiraterone acetate: A retrospective cohort studyBenjamin Lowentritt, Dominic Pilon, Dexter Waters, et al.
Advances in Therapy|June 17, 2025
Comparison of Real-World Outcomes between Patients with BRCA1/2-Positive and Homologous Recombination Repair-Negative Metastatic Castration-Sensitive Prostate CancerMehmet A Bilen, Sabree Burbage, Carmine Rossi, et al.
Journal of Intellectual Disability Research : JIDR|October 20, 2025
Implementation of Online Mindfulness With Peer Mentoring for Parent and Sibling Carers of People With Intellectual and Developmental DisabilitiesCaitlin A Murray, Nikita K Hayden, Alex Gordon-Brown, et al.
Chemical Communications (Cambridge, England)|September 25, 2014
Dual doping effects (site blockage and electronic promotion) imposed by adatoms on Pd nanocrystals for catalytic hydrogen productionS Jones, S M Fairclough, M Gordon-Brown, et al.
Prostate Cancer and Prostatic Diseases|October 1, 2021
Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studiesErik Margolis, Gordon Brown, Alan Partin, et al.
International Urology and Nephrology|March 19, 2024
Renal mass imaging modalities: does body mass index (BMI) matter?Young Son, Mark E Quiring, Raeann M Dalton, et al.
Urology|January 31, 2026
Homologous recombination repair mutations, next-generation sequencing testing, and treatment progression by race among patients with metastatic castration-sensitive prostate cancerMehmet A Bilen, Neal Shore, Sabree Burbage, et al.
Pageof 9